Miller T P, Greenberger P A, Patterson R
Department of Medicine, Northwestern University Medical School, Chicago.
Chest. 1992 Aug;102(2):515-8. doi: 10.1378/chest.102.2.515.
We evaluated various patient characteristics in patients hospitalized for asthma during 1987 to 1990. Potentially fatal asthma was identified in 26 of 87 adult patients (29.9 percent) hospitalized. Patients with PFA had increased frequency of prednisone use prior to hospitalization (p less than 0.001), shorter duration of symptoms before hospitalization (p less than 0.001), longer hospitalization (p less than 0.001), were more likely to have had three or more prior hospitalizations (p less than 0.001), and had reduced presenting peak expiratory flow rates (p less than 0.05). Major psychiatric diagnoses and noncompliance were significantly related to PFA cases. The diagnosis of PFA identifies a higher risk patient with asthma. The data suggest that at the time of hospitalization the PFA patient has had a shorter recognized prodrome of increased respiratory symptoms, reduced peak expiratory flow rates and greater likelihood of major psychiatric disease or noncompliance. Effective ambulatory control of PFA and non-PFA is advisable with earlier use and higher dosages of oral corticosteroids.
我们评估了1987年至1990年期间因哮喘住院患者的各种特征。在87名住院成年患者中,有26名(29.9%)被确诊为潜在致命性哮喘。潜在致命性哮喘患者在住院前使用泼尼松的频率增加(p<0.001),住院前症状持续时间较短(p<0.001),住院时间较长(p<0.001),更有可能有三次或更多次既往住院史(p<0.001),且就诊时的呼气峰值流速降低(p<0.05)。主要精神疾病诊断和不依从性与潜在致命性哮喘病例显著相关。潜在致命性哮喘的诊断可识别出哮喘风险较高的患者。数据表明,在住院时,潜在致命性哮喘患者已出现的呼吸道症状加重、呼气峰值流速降低以及患有主要精神疾病或不依从的可能性增加的前驱症状时间较短。建议对潜在致命性哮喘和非潜在致命性哮喘患者进行有效的门诊控制,早期使用并增加口服糖皮质激素的剂量。